FDA Approves Adagrasib for KRAS G12C–Mutated CRC
The US Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics, Inc.) with cetuximab for ...
Read moreDetailsThe US Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics, Inc.) with cetuximab for ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info